Integrated laser platform receives CE Mark approval
February 7th 2014The Optimis Fusion integrated laser platform from Quantel Medical has received CE Mark approval. The system is a combination of advanced selective laser trabeculoplasty photoregeneration therapy with traditional YAG photodisruption treatment for treating both cataract and glaucoma.
Pre-op assessment should consider interactions between demographic and ocular factors
February 6th 2014Corneal refractive surgery may be more successful in eyes in which the cylinder mainly originates from the anterior cornea; therefore, in candidates for refractive surgery, surgeons should carefully assess the interaction between topographic, refractive and ocular residual astigmatism (ORA) to identify those at high risk for having significant differences between subjective cylinder and topographic astigmatism.
Retinal oxygen metabolism differs in glaucoma patients
February 5th 2014Patients with advanced glaucoma have higher oxygen saturation in venules and lower arteriovenous difference in oxygen saturation compared with healthy individuals. The decrease in arteriovenous difference in patients with severe glaucoma may be related to lower oxygen consumption secondary to neuropathy
Rebound tonometer comparable to Goldmann applanation
January 23rd 2014IOP measurements obtained with the rebound tonometer (Icare Pro) are more comparable to those achieved with the Goldmann applanation tonometer than those obtained with ultra-high-speed Scheimpflug technology, according to a recent study.
Combination procedure offers many advantages
January 17th 2014The combination of sutureless coaxial microincision cataract surgery and 23-gauge vitrectomy confers many advantages, including less wound leakage, good anterior chamber stability, safety, decreased inflammation and faster rehabilitation after surgery, according to the authors of a study published recently in Retina: The Journal of Retinal and Vitreous Diseases.
CXL therapy benefits patients with progressive keratoconus
January 10th 2014Collagen crosslinking (CXL) in patients with progressive keratoconus was found to be effective after 2 years in improving uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), topographic metrics, and most corneal higher-order aberrations, according to a study published in Cornea: The Journal of Cornea and External Disease. Researchers noted that there was a significant reduction in apical keratometry, which directly correlated with improvements in visual acuity
AS eye drops improve ocular surface dryness and decrease epithelial damage
January 9th 2014Autologous serum (AS) eye drops on the ocular surface of patients with bilateral severe dry eye improved not only ocular surface dryness, but decreased damage of the epithelium as well, as measured by clinical, laboratory, and subjective criteria, according to results from a study recently published in Current Eye Research
Steroid-induced CSC may only occur in vulnerable patients
January 8th 2014Steroid-induced central serous chorioretinopathy (CSC) may only occur in select patients who are vulnerable, rather than having a dose-dependent effect, according to a recent study published in Investigative Ophthalmology & Visual Science
NICE makes implant available for patients with DME
December 20th 2013Patients with pseudophakic eye who have undergone cataract will have greater access to fluocinolone acetonide (Iluvien, Alimera Sciences) for the treatment of chronic diabetic macular oedema (DME) that is considered refractive to available therapies. The National Institute for Health and Care Excellence (NICE) has published a final guidance recommending fluocinolone acetonide, making it available for patients through the National Health Service (NHS).
Re-treatment with SLT after initial treatment failure does not reduce IOP
December 19th 2013Two treatments with selective laser trabeculoplasty (SLT) in the same area of the trabecular meshwork (TM) do not significantly affect IOP, compared with two SLT treatments in differing areas, according to a recently published study.
Meta-analysis shows anti-VEGF agents comparable in efficacy
December 18th 2013All anti-vascular endothelial growth factor (VEGF) agents improve visual acuity compared with laser photocoagulation, but there is insufficient evidence to distinguish the performance of any single anti-VEGF agent over another, according to results from a recently-conducted meta-analysis from researchers at the Institute for Clinical and Economic Review. The safety of bevacizumab also remains uncertain.
Chloroquine retinopathy may progress long after drug cessation
December 13th 2013Despite treatment, chloroquine retinopathy may continue to progress long after drug cessation, according to a study published on-line by the British Journal of Ophthalmology. Further, disease progression may be accompanied by cystoid macular oedema, epiretinal membrane formation and peripheral involvement.
Swept-source OCT better for imaging posterior sclera, not lamina cribrosa
December 12th 2013Swept-source optical coherence tomography (OCT) may be superior to enhanced depth imaging (EDI)-OCT in imaging the posterior sclera, but not in imaging the lamina cribrosa, according to a study published online in the American Journal of Ophthalmology.
High-risk patients benefit from home monitoring
December 6th 2013The Home Monitoring of the Eye (HOME) study, conducted in AREDS2 clinical centres, has demonstrated that patients at high-risk of developing choroidal neovascularization (CNV) - the neovascular or wet phase of AMD - benefit from using the ForeseeHome monitoring device (Notal Vision).
Encouraging results for dry AMD treatment revealed
December 4th 2013Roche has announced additional encouraging results of a phase II study with lampalizumab to treat patients with geographic atrophy (GA). The MAHALO study data was presented during the Retina subspeciality day at AAO 2013 in New Orleans, Louisiana, USA.
Protein from fat-derived stem cells may prevent retinal damage
November 28th 2013Progranulin, a protein found in fat-derived stem cells, may reverse and perhaps prevent age-related, light-induced retinal damage, according to results from a study done in a mouse model by researchers from Gifu Pharmaceutical University and Gifu University, Japan.
Lab test launched for early detection of Sjögren's syndrome
November 23rd 2013Nicox has launched Sjö, an advanced diagnostic panel for the early detection of Sjögren's syndrome, and has formed a partnership with the Sjögren's Syndrome Foundation to raise aware of this disease among eye care professionals.
Preclinical results yield positive results for dry eye treatment
November 22nd 2013ML7 has the potential to bring an effective, targeted therapeutic response in patients who suffer from dry eye syndromes. Preclinical trials of the eye-drop formulation of Neuroptis Biotech's ML7 product have yielded positive results, and have recently been published.